article_metadata: Haidong Ai Ting Gong Yongbiao Ma Guixu Ma Wei Ding Weibao Ding Wenjuan Wang Xuelin Zhao
article_metadata: 10.3389/fimmu.2024.1358602
article_metadata: Front Immunol
article_metadata: 2024 May 28:15:1358602.
article_metadata: atezolizumab plus bevacizumab conversion therapy immunotherapy intermediate-stage unresectable hepatocellular carcinoma transarterial chemoembolization
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38863699/
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Combined Chemotherapy Protocols / adverse effects Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bevacizumab / administration & dosage Bevacizumab / therapeutic use Carcinoma, Hepatocellular / pathology Carcinoma, Hepatocellular / therapy Chemoembolization, Therapeutic / methods Liver Neoplasms / drug therapy Liver Neoplasms / pathology Liver Neoplasms / therapy
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Combined Chemotherapy Protocols / adverse effects Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bevacizumab / administration & dosage Bevacizumab / therapeutic use Carcinoma, Hepatocellular / pathology Carcinoma, Hepatocellular / therapy Chemoembolization, Therapeutic / methods Liver Neoplasms / drug therapy Liver Neoplasms / pathology Liver Neoplasms / therapy Case Reports Review Combined Modality Therapy Humans Male Middle Aged Neoplasm Staging Treatment Outcome atezolizumab Bevacizumab Antibodies, Monoclonal, Humanized
article_metadata: PMC11165049
article_metadata: 38863699
article_metadata: Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review
article_metadata: 2024